Global PD-1 Antibody Drug Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
PD-1 is an immune checkpoint inhibitor, which is relatively widely used clinically
The global PD-1 Antibody Drug market size is projected to grow from US$ 32280 million in 2023 to US$ 85010 million in 2030; it is expected to grow at a CAGR of 14.8% from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “PD-1 Antibody Drug Industry Forecast” looks at past sales and reviews total world PD-1 Antibody Drug sales in 2023, providing a comprehensive analysis by region and market sector of projected PD-1 Antibody Drug sales for 2024 through 2030. With PD-1 Antibody Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world PD-1 Antibody Drug industry.
This Insight Report provides a comprehensive analysis of the global PD-1 Antibody Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on PD-1 Antibody Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global PD-1 Antibody Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for PD-1 Antibody Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global PD-1 Antibody Drug.
United States market for PD-1 Antibody Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for PD-1 Antibody Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for PD-1 Antibody Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key PD-1 Antibody Drug players cover Novartis, Thermo Fisher, InvivoGen, BioVision Inc. and Abcam, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of PD-1 Antibody Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
What is the 10-year outlook for the global PD-1 Antibody Drug market?
What factors are driving PD-1 Antibody Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do PD-1 Antibody Drug market opportunities vary by end market size?
How does PD-1 Antibody Drug break out type, application?
PD-1 is an immune checkpoint inhibitor, which is relatively widely used clinically
The global PD-1 Antibody Drug market size is projected to grow from US$ 32280 million in 2023 to US$ 85010 million in 2030; it is expected to grow at a CAGR of 14.8% from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “PD-1 Antibody Drug Industry Forecast” looks at past sales and reviews total world PD-1 Antibody Drug sales in 2023, providing a comprehensive analysis by region and market sector of projected PD-1 Antibody Drug sales for 2024 through 2030. With PD-1 Antibody Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world PD-1 Antibody Drug industry.
This Insight Report provides a comprehensive analysis of the global PD-1 Antibody Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on PD-1 Antibody Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global PD-1 Antibody Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for PD-1 Antibody Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global PD-1 Antibody Drug.
United States market for PD-1 Antibody Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for PD-1 Antibody Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for PD-1 Antibody Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key PD-1 Antibody Drug players cover Novartis, Thermo Fisher, InvivoGen, BioVision Inc. and Abcam, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of PD-1 Antibody Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
- Pembrolizumab
- Nivolumab
- Sindilimab
- Toripalimab
- Other
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
- Thermo Fisher
- InvivoGen
- BioVision Inc.
- Abcam
- Bristol-Myers Squibb
- Merck
- Ono Pharmaceutical Co., Ltd
- Eli Lilly
- Chugai Pharmaceutical Co., Ltd
- BeiGene
- AbbVie
- TG Therapeutics, Inc
- Beijing Yiqiao Shenzhou Technology Co., Ltd.
- 3SBio
What is the 10-year outlook for the global PD-1 Antibody Drug market?
What factors are driving PD-1 Antibody Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do PD-1 Antibody Drug market opportunities vary by end market size?
How does PD-1 Antibody Drug break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global PD-1 Antibody Drug Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for PD-1 Antibody Drug by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for PD-1 Antibody Drug by Country/Region, 2019, 2023 & 2030
2.2 PD-1 Antibody Drug Segment by Type
2.2.1 Pembrolizumab
2.2.2 Nivolumab
2.2.3 Sindilimab
2.2.4 Toripalimab
2.2.5 Other
2.3 PD-1 Antibody Drug Sales by Type
2.3.1 Global PD-1 Antibody Drug Sales Market Share by Type (2019-2024)
2.3.2 Global PD-1 Antibody Drug Revenue and Market Share by Type (2019-2024)
2.3.3 Global PD-1 Antibody Drug Sale Price by Type (2019-2024)
2.4 PD-1 Antibody Drug Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 PD-1 Antibody Drug Sales by Application
2.5.1 Global PD-1 Antibody Drug Sale Market Share by Application (2019-2024)
2.5.2 Global PD-1 Antibody Drug Revenue and Market Share by Application (2019-2024)
2.5.3 Global PD-1 Antibody Drug Sale Price by Application (2019-2024)
3 GLOBAL PD-1 ANTIBODY DRUG BY COMPANY
3.1 Global PD-1 Antibody Drug Breakdown Data by Company
3.1.1 Global PD-1 Antibody Drug Annual Sales by Company (2019-2024)
3.1.2 Global PD-1 Antibody Drug Sales Market Share by Company (2019-2024)
3.2 Global PD-1 Antibody Drug Annual Revenue by Company (2019-2024)
3.2.1 Global PD-1 Antibody Drug Revenue by Company (2019-2024)
3.2.2 Global PD-1 Antibody Drug Revenue Market Share by Company (2019-2024)
3.3 Global PD-1 Antibody Drug Sale Price by Company
3.4 Key Manufacturers PD-1 Antibody Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers PD-1 Antibody Drug Product Location Distribution
3.4.2 Players PD-1 Antibody Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PD-1 ANTIBODY DRUG BY GEOGRAPHIC REGION
4.1 World Historic PD-1 Antibody Drug Market Size by Geographic Region (2019-2024)
4.1.1 Global PD-1 Antibody Drug Annual Sales by Geographic Region (2019-2024)
4.1.2 Global PD-1 Antibody Drug Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic PD-1 Antibody Drug Market Size by Country/Region (2019-2024)
4.2.1 Global PD-1 Antibody Drug Annual Sales by Country/Region (2019-2024)
4.2.2 Global PD-1 Antibody Drug Annual Revenue by Country/Region (2019-2024)
4.3 Americas PD-1 Antibody Drug Sales Growth
4.4 APAC PD-1 Antibody Drug Sales Growth
4.5 Europe PD-1 Antibody Drug Sales Growth
4.6 Middle East & Africa PD-1 Antibody Drug Sales Growth
5 AMERICAS
5.1 Americas PD-1 Antibody Drug Sales by Country
5.1.1 Americas PD-1 Antibody Drug Sales by Country (2019-2024)
5.1.2 Americas PD-1 Antibody Drug Revenue by Country (2019-2024)
5.2 Americas PD-1 Antibody Drug Sales by Type
5.3 Americas PD-1 Antibody Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC PD-1 Antibody Drug Sales by Region
6.1.1 APAC PD-1 Antibody Drug Sales by Region (2019-2024)
6.1.2 APAC PD-1 Antibody Drug Revenue by Region (2019-2024)
6.2 APAC PD-1 Antibody Drug Sales by Type
6.3 APAC PD-1 Antibody Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe PD-1 Antibody Drug by Country
7.1.1 Europe PD-1 Antibody Drug Sales by Country (2019-2024)
7.1.2 Europe PD-1 Antibody Drug Revenue by Country (2019-2024)
7.2 Europe PD-1 Antibody Drug Sales by Type
7.3 Europe PD-1 Antibody Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa PD-1 Antibody Drug by Country
8.1.1 Middle East & Africa PD-1 Antibody Drug Sales by Country (2019-2024)
8.1.2 Middle East & Africa PD-1 Antibody Drug Revenue by Country (2019-2024)
8.2 Middle East & Africa PD-1 Antibody Drug Sales by Type
8.3 Middle East & Africa PD-1 Antibody Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of PD-1 Antibody Drug
10.3 Manufacturing Process Analysis of PD-1 Antibody Drug
10.4 Industry Chain Structure of PD-1 Antibody Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 PD-1 Antibody Drug Distributors
11.3 PD-1 Antibody Drug Customer
12 WORLD FORECAST REVIEW FOR PD-1 ANTIBODY DRUG BY GEOGRAPHIC REGION
12.1 Global PD-1 Antibody Drug Market Size Forecast by Region
12.1.1 Global PD-1 Antibody Drug Forecast by Region (2025-2030)
12.1.2 Global PD-1 Antibody Drug Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global PD-1 Antibody Drug Forecast by Type
12.7 Global PD-1 Antibody Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis PD-1 Antibody Drug Product Portfolios and Specifications
13.1.3 Novartis PD-1 Antibody Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Thermo Fisher
13.2.1 Thermo Fisher Company Information
13.2.2 Thermo Fisher PD-1 Antibody Drug Product Portfolios and Specifications
13.2.3 Thermo Fisher PD-1 Antibody Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Thermo Fisher Main Business Overview
13.2.5 Thermo Fisher Latest Developments
13.3 InvivoGen
13.3.1 InvivoGen Company Information
13.3.2 InvivoGen PD-1 Antibody Drug Product Portfolios and Specifications
13.3.3 InvivoGen PD-1 Antibody Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 InvivoGen Main Business Overview
13.3.5 InvivoGen Latest Developments
13.4 BioVision Inc.
13.4.1 BioVision Inc. Company Information
13.4.2 BioVision Inc. PD-1 Antibody Drug Product Portfolios and Specifications
13.4.3 BioVision Inc. PD-1 Antibody Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 BioVision Inc. Main Business Overview
13.4.5 BioVision Inc. Latest Developments
13.5 Abcam
13.5.1 Abcam Company Information
13.5.2 Abcam PD-1 Antibody Drug Product Portfolios and Specifications
13.5.3 Abcam PD-1 Antibody Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Abcam Main Business Overview
13.5.5 Abcam Latest Developments
13.6 Bristol-Myers Squibb
13.6.1 Bristol-Myers Squibb Company Information
13.6.2 Bristol-Myers Squibb PD-1 Antibody Drug Product Portfolios and Specifications
13.6.3 Bristol-Myers Squibb PD-1 Antibody Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Bristol-Myers Squibb Main Business Overview
13.6.5 Bristol-Myers Squibb Latest Developments
13.7 Merck
13.7.1 Merck Company Information
13.7.2 Merck PD-1 Antibody Drug Product Portfolios and Specifications
13.7.3 Merck PD-1 Antibody Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Merck Main Business Overview
13.7.5 Merck Latest Developments
13.8 Ono Pharmaceutical Co., Ltd
13.8.1 Ono Pharmaceutical Co., Ltd Company Information
13.8.2 Ono Pharmaceutical Co., Ltd PD-1 Antibody Drug Product Portfolios and Specifications
13.8.3 Ono Pharmaceutical Co., Ltd PD-1 Antibody Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Ono Pharmaceutical Co., Ltd Main Business Overview
13.8.5 Ono Pharmaceutical Co., Ltd Latest Developments
13.9 Eli Lilly
13.9.1 Eli Lilly Company Information
13.9.2 Eli Lilly PD-1 Antibody Drug Product Portfolios and Specifications
13.9.3 Eli Lilly PD-1 Antibody Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Eli Lilly Main Business Overview
13.9.5 Eli Lilly Latest Developments
13.10 Chugai Pharmaceutical Co., Ltd
13.10.1 Chugai Pharmaceutical Co., Ltd Company Information
13.10.2 Chugai Pharmaceutical Co., Ltd PD-1 Antibody Drug Product Portfolios and Specifications
13.10.3 Chugai Pharmaceutical Co., Ltd PD-1 Antibody Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Chugai Pharmaceutical Co., Ltd Main Business Overview
13.10.5 Chugai Pharmaceutical Co., Ltd Latest Developments
13.11 BeiGene
13.11.1 BeiGene Company Information
13.11.2 BeiGene PD-1 Antibody Drug Product Portfolios and Specifications
13.11.3 BeiGene PD-1 Antibody Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 BeiGene Main Business Overview
13.11.5 BeiGene Latest Developments
13.12 AbbVie
13.12.1 AbbVie Company Information
13.12.2 AbbVie PD-1 Antibody Drug Product Portfolios and Specifications
13.12.3 AbbVie PD-1 Antibody Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 AbbVie Main Business Overview
13.12.5 AbbVie Latest Developments
13.13 TG Therapeutics, Inc
13.13.1 TG Therapeutics, Inc Company Information
13.13.2 TG Therapeutics, Inc PD-1 Antibody Drug Product Portfolios and Specifications
13.13.3 TG Therapeutics, Inc PD-1 Antibody Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 TG Therapeutics, Inc Main Business Overview
13.13.5 TG Therapeutics, Inc Latest Developments
13.14 Beijing Yiqiao Shenzhou Technology Co., Ltd.
13.14.1 Beijing Yiqiao Shenzhou Technology Co., Ltd. Company Information
13.14.2 Beijing Yiqiao Shenzhou Technology Co., Ltd. PD-1 Antibody Drug Product Portfolios and Specifications
13.14.3 Beijing Yiqiao Shenzhou Technology Co., Ltd. PD-1 Antibody Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Beijing Yiqiao Shenzhou Technology Co., Ltd. Main Business Overview
13.14.5 Beijing Yiqiao Shenzhou Technology Co., Ltd. Latest Developments
13.15 3SBio
13.15.1 3SBio Company Information
13.15.2 3SBio PD-1 Antibody Drug Product Portfolios and Specifications
13.15.3 3SBio PD-1 Antibody Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 3SBio Main Business Overview
13.15.5 3SBio Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global PD-1 Antibody Drug Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for PD-1 Antibody Drug by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for PD-1 Antibody Drug by Country/Region, 2019, 2023 & 2030
2.2 PD-1 Antibody Drug Segment by Type
2.2.1 Pembrolizumab
2.2.2 Nivolumab
2.2.3 Sindilimab
2.2.4 Toripalimab
2.2.5 Other
2.3 PD-1 Antibody Drug Sales by Type
2.3.1 Global PD-1 Antibody Drug Sales Market Share by Type (2019-2024)
2.3.2 Global PD-1 Antibody Drug Revenue and Market Share by Type (2019-2024)
2.3.3 Global PD-1 Antibody Drug Sale Price by Type (2019-2024)
2.4 PD-1 Antibody Drug Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 PD-1 Antibody Drug Sales by Application
2.5.1 Global PD-1 Antibody Drug Sale Market Share by Application (2019-2024)
2.5.2 Global PD-1 Antibody Drug Revenue and Market Share by Application (2019-2024)
2.5.3 Global PD-1 Antibody Drug Sale Price by Application (2019-2024)
3 GLOBAL PD-1 ANTIBODY DRUG BY COMPANY
3.1 Global PD-1 Antibody Drug Breakdown Data by Company
3.1.1 Global PD-1 Antibody Drug Annual Sales by Company (2019-2024)
3.1.2 Global PD-1 Antibody Drug Sales Market Share by Company (2019-2024)
3.2 Global PD-1 Antibody Drug Annual Revenue by Company (2019-2024)
3.2.1 Global PD-1 Antibody Drug Revenue by Company (2019-2024)
3.2.2 Global PD-1 Antibody Drug Revenue Market Share by Company (2019-2024)
3.3 Global PD-1 Antibody Drug Sale Price by Company
3.4 Key Manufacturers PD-1 Antibody Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers PD-1 Antibody Drug Product Location Distribution
3.4.2 Players PD-1 Antibody Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PD-1 ANTIBODY DRUG BY GEOGRAPHIC REGION
4.1 World Historic PD-1 Antibody Drug Market Size by Geographic Region (2019-2024)
4.1.1 Global PD-1 Antibody Drug Annual Sales by Geographic Region (2019-2024)
4.1.2 Global PD-1 Antibody Drug Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic PD-1 Antibody Drug Market Size by Country/Region (2019-2024)
4.2.1 Global PD-1 Antibody Drug Annual Sales by Country/Region (2019-2024)
4.2.2 Global PD-1 Antibody Drug Annual Revenue by Country/Region (2019-2024)
4.3 Americas PD-1 Antibody Drug Sales Growth
4.4 APAC PD-1 Antibody Drug Sales Growth
4.5 Europe PD-1 Antibody Drug Sales Growth
4.6 Middle East & Africa PD-1 Antibody Drug Sales Growth
5 AMERICAS
5.1 Americas PD-1 Antibody Drug Sales by Country
5.1.1 Americas PD-1 Antibody Drug Sales by Country (2019-2024)
5.1.2 Americas PD-1 Antibody Drug Revenue by Country (2019-2024)
5.2 Americas PD-1 Antibody Drug Sales by Type
5.3 Americas PD-1 Antibody Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC PD-1 Antibody Drug Sales by Region
6.1.1 APAC PD-1 Antibody Drug Sales by Region (2019-2024)
6.1.2 APAC PD-1 Antibody Drug Revenue by Region (2019-2024)
6.2 APAC PD-1 Antibody Drug Sales by Type
6.3 APAC PD-1 Antibody Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe PD-1 Antibody Drug by Country
7.1.1 Europe PD-1 Antibody Drug Sales by Country (2019-2024)
7.1.2 Europe PD-1 Antibody Drug Revenue by Country (2019-2024)
7.2 Europe PD-1 Antibody Drug Sales by Type
7.3 Europe PD-1 Antibody Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa PD-1 Antibody Drug by Country
8.1.1 Middle East & Africa PD-1 Antibody Drug Sales by Country (2019-2024)
8.1.2 Middle East & Africa PD-1 Antibody Drug Revenue by Country (2019-2024)
8.2 Middle East & Africa PD-1 Antibody Drug Sales by Type
8.3 Middle East & Africa PD-1 Antibody Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of PD-1 Antibody Drug
10.3 Manufacturing Process Analysis of PD-1 Antibody Drug
10.4 Industry Chain Structure of PD-1 Antibody Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 PD-1 Antibody Drug Distributors
11.3 PD-1 Antibody Drug Customer
12 WORLD FORECAST REVIEW FOR PD-1 ANTIBODY DRUG BY GEOGRAPHIC REGION
12.1 Global PD-1 Antibody Drug Market Size Forecast by Region
12.1.1 Global PD-1 Antibody Drug Forecast by Region (2025-2030)
12.1.2 Global PD-1 Antibody Drug Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global PD-1 Antibody Drug Forecast by Type
12.7 Global PD-1 Antibody Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis PD-1 Antibody Drug Product Portfolios and Specifications
13.1.3 Novartis PD-1 Antibody Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Thermo Fisher
13.2.1 Thermo Fisher Company Information
13.2.2 Thermo Fisher PD-1 Antibody Drug Product Portfolios and Specifications
13.2.3 Thermo Fisher PD-1 Antibody Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Thermo Fisher Main Business Overview
13.2.5 Thermo Fisher Latest Developments
13.3 InvivoGen
13.3.1 InvivoGen Company Information
13.3.2 InvivoGen PD-1 Antibody Drug Product Portfolios and Specifications
13.3.3 InvivoGen PD-1 Antibody Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 InvivoGen Main Business Overview
13.3.5 InvivoGen Latest Developments
13.4 BioVision Inc.
13.4.1 BioVision Inc. Company Information
13.4.2 BioVision Inc. PD-1 Antibody Drug Product Portfolios and Specifications
13.4.3 BioVision Inc. PD-1 Antibody Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 BioVision Inc. Main Business Overview
13.4.5 BioVision Inc. Latest Developments
13.5 Abcam
13.5.1 Abcam Company Information
13.5.2 Abcam PD-1 Antibody Drug Product Portfolios and Specifications
13.5.3 Abcam PD-1 Antibody Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Abcam Main Business Overview
13.5.5 Abcam Latest Developments
13.6 Bristol-Myers Squibb
13.6.1 Bristol-Myers Squibb Company Information
13.6.2 Bristol-Myers Squibb PD-1 Antibody Drug Product Portfolios and Specifications
13.6.3 Bristol-Myers Squibb PD-1 Antibody Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Bristol-Myers Squibb Main Business Overview
13.6.5 Bristol-Myers Squibb Latest Developments
13.7 Merck
13.7.1 Merck Company Information
13.7.2 Merck PD-1 Antibody Drug Product Portfolios and Specifications
13.7.3 Merck PD-1 Antibody Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Merck Main Business Overview
13.7.5 Merck Latest Developments
13.8 Ono Pharmaceutical Co., Ltd
13.8.1 Ono Pharmaceutical Co., Ltd Company Information
13.8.2 Ono Pharmaceutical Co., Ltd PD-1 Antibody Drug Product Portfolios and Specifications
13.8.3 Ono Pharmaceutical Co., Ltd PD-1 Antibody Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Ono Pharmaceutical Co., Ltd Main Business Overview
13.8.5 Ono Pharmaceutical Co., Ltd Latest Developments
13.9 Eli Lilly
13.9.1 Eli Lilly Company Information
13.9.2 Eli Lilly PD-1 Antibody Drug Product Portfolios and Specifications
13.9.3 Eli Lilly PD-1 Antibody Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Eli Lilly Main Business Overview
13.9.5 Eli Lilly Latest Developments
13.10 Chugai Pharmaceutical Co., Ltd
13.10.1 Chugai Pharmaceutical Co., Ltd Company Information
13.10.2 Chugai Pharmaceutical Co., Ltd PD-1 Antibody Drug Product Portfolios and Specifications
13.10.3 Chugai Pharmaceutical Co., Ltd PD-1 Antibody Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Chugai Pharmaceutical Co., Ltd Main Business Overview
13.10.5 Chugai Pharmaceutical Co., Ltd Latest Developments
13.11 BeiGene
13.11.1 BeiGene Company Information
13.11.2 BeiGene PD-1 Antibody Drug Product Portfolios and Specifications
13.11.3 BeiGene PD-1 Antibody Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 BeiGene Main Business Overview
13.11.5 BeiGene Latest Developments
13.12 AbbVie
13.12.1 AbbVie Company Information
13.12.2 AbbVie PD-1 Antibody Drug Product Portfolios and Specifications
13.12.3 AbbVie PD-1 Antibody Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 AbbVie Main Business Overview
13.12.5 AbbVie Latest Developments
13.13 TG Therapeutics, Inc
13.13.1 TG Therapeutics, Inc Company Information
13.13.2 TG Therapeutics, Inc PD-1 Antibody Drug Product Portfolios and Specifications
13.13.3 TG Therapeutics, Inc PD-1 Antibody Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 TG Therapeutics, Inc Main Business Overview
13.13.5 TG Therapeutics, Inc Latest Developments
13.14 Beijing Yiqiao Shenzhou Technology Co., Ltd.
13.14.1 Beijing Yiqiao Shenzhou Technology Co., Ltd. Company Information
13.14.2 Beijing Yiqiao Shenzhou Technology Co., Ltd. PD-1 Antibody Drug Product Portfolios and Specifications
13.14.3 Beijing Yiqiao Shenzhou Technology Co., Ltd. PD-1 Antibody Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Beijing Yiqiao Shenzhou Technology Co., Ltd. Main Business Overview
13.14.5 Beijing Yiqiao Shenzhou Technology Co., Ltd. Latest Developments
13.15 3SBio
13.15.1 3SBio Company Information
13.15.2 3SBio PD-1 Antibody Drug Product Portfolios and Specifications
13.15.3 3SBio PD-1 Antibody Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 3SBio Main Business Overview
13.15.5 3SBio Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. PD-1 Antibody Drug Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. PD-1 Antibody Drug Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Pembrolizumab
Table 4. Major Players of Nivolumab
Table 5. Major Players of Sindilimab
Table 6. Major Players of Toripalimab
Table 7. Major Players of Other
Table 8. Global PD-1 Antibody Drug Sales by Type (2019-2024) & (K Units)
Table 9. Global PD-1 Antibody Drug Sales Market Share by Type (2019-2024)
Table 10. Global PD-1 Antibody Drug Revenue by Type (2019-2024) & ($ million)
Table 11. Global PD-1 Antibody Drug Revenue Market Share by Type (2019-2024)
Table 12. Global PD-1 Antibody Drug Sale Price by Type (2019-2024) & (US$/Unit)
Table 13. Global PD-1 Antibody Drug Sales by Application (2019-2024) & (K Units)
Table 14. Global PD-1 Antibody Drug Sales Market Share by Application (2019-2024)
Table 15. Global PD-1 Antibody Drug Revenue by Application (2019-2024)
Table 16. Global PD-1 Antibody Drug Revenue Market Share by Application (2019-2024)
Table 17. Global PD-1 Antibody Drug Sale Price by Application (2019-2024) & (US$/Unit)
Table 18. Global PD-1 Antibody Drug Sales by Company (2019-2024) & (K Units)
Table 19. Global PD-1 Antibody Drug Sales Market Share by Company (2019-2024)
Table 20. Global PD-1 Antibody Drug Revenue by Company (2019-2024) ($ Millions)
Table 21. Global PD-1 Antibody Drug Revenue Market Share by Company (2019-2024)
Table 22. Global PD-1 Antibody Drug Sale Price by Company (2019-2024) & (US$/Unit)
Table 23. Key Manufacturers PD-1 Antibody Drug Producing Area Distribution and Sales Area
Table 24. Players PD-1 Antibody Drug Products Offered
Table 25. PD-1 Antibody Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global PD-1 Antibody Drug Sales by Geographic Region (2019-2024) & (K Units)
Table 29. Global PD-1 Antibody Drug Sales Market Share Geographic Region (2019-2024)
Table 30. Global PD-1 Antibody Drug Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global PD-1 Antibody Drug Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global PD-1 Antibody Drug Sales by Country/Region (2019-2024) & (K Units)
Table 33. Global PD-1 Antibody Drug Sales Market Share by Country/Region (2019-2024)
Table 34. Global PD-1 Antibody Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global PD-1 Antibody Drug Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas PD-1 Antibody Drug Sales by Country (2019-2024) & (K Units)
Table 37. Americas PD-1 Antibody Drug Sales Market Share by Country (2019-2024)
Table 38. Americas PD-1 Antibody Drug Revenue by Country (2019-2024) & ($ Millions)
Table 39. Americas PD-1 Antibody Drug Revenue Market Share by Country (2019-2024)
Table 40. Americas PD-1 Antibody Drug Sales by Type (2019-2024) & (K Units)
Table 41. Americas PD-1 Antibody Drug Sales by Application (2019-2024) & (K Units)
Table 42. APAC PD-1 Antibody Drug Sales by Region (2019-2024) & (K Units)
Table 43. APAC PD-1 Antibody Drug Sales Market Share by Region (2019-2024)
Table 44. APAC PD-1 Antibody Drug Revenue by Region (2019-2024) & ($ Millions)
Table 45. APAC PD-1 Antibody Drug Revenue Market Share by Region (2019-2024)
Table 46. APAC PD-1 Antibody Drug Sales by Type (2019-2024) & (K Units)
Table 47. APAC PD-1 Antibody Drug Sales by Application (2019-2024) & (K Units)
Table 48. Europe PD-1 Antibody Drug Sales by Country (2019-2024) & (K Units)
Table 49. Europe PD-1 Antibody Drug Sales Market Share by Country (2019-2024)
Table 50. Europe PD-1 Antibody Drug Revenue by Country (2019-2024) & ($ Millions)
Table 51. Europe PD-1 Antibody Drug Revenue Market Share by Country (2019-2024)
Table 52. Europe PD-1 Antibody Drug Sales by Type (2019-2024) & (K Units)
Table 53. Europe PD-1 Antibody Drug Sales by Application (2019-2024) & (K Units)
Table 54. Middle East & Africa PD-1 Antibody Drug Sales by Country (2019-2024) & (K Units)
Table 55. Middle East & Africa PD-1 Antibody Drug Sales Market Share by Country (2019-2024)
Table 56. Middle East & Africa PD-1 Antibody Drug Revenue by Country (2019-2024) & ($ Millions)
Table 57. Middle East & Africa PD-1 Antibody Drug Revenue Market Share by Country (2019-2024)
Table 58. Middle East & Africa PD-1 Antibody Drug Sales by Type (2019-2024) & (K Units)
Table 59. Middle East & Africa PD-1 Antibody Drug Sales by Application (2019-2024) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of PD-1 Antibody Drug
Table 61. Key Market Challenges & Risks of PD-1 Antibody Drug
Table 62. Key Industry Trends of PD-1 Antibody Drug
Table 63. PD-1 Antibody Drug Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. PD-1 Antibody Drug Distributors List
Table 66. PD-1 Antibody Drug Customer List
Table 67. Global PD-1 Antibody Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 68. Global PD-1 Antibody Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 69. Americas PD-1 Antibody Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 70. Americas PD-1 Antibody Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. APAC PD-1 Antibody Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 72. APAC PD-1 Antibody Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Europe PD-1 Antibody Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Europe PD-1 Antibody Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Middle East & Africa PD-1 Antibody Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 76. Middle East & Africa PD-1 Antibody Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Global PD-1 Antibody Drug Sales Forecast by Type (2025-2030) & (K Units)
Table 78. Global PD-1 Antibody Drug Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 79. Global PD-1 Antibody Drug Sales Forecast by Application (2025-2030) & (K Units)
Table 80. Global PD-1 Antibody Drug Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 81. Novartis Basic Information, PD-1 Antibody Drug Manufacturing Base, Sales Area and Its Competitors
Table 82. Novartis PD-1 Antibody Drug Product Portfolios and Specifications
Table 83. Novartis PD-1 Antibody Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 84. Novartis Main Business
Table 85. Novartis Latest Developments
Table 86. Thermo Fisher Basic Information, PD-1 Antibody Drug Manufacturing Base, Sales Area and Its Competitors
Table 87. Thermo Fisher PD-1 Antibody Drug Product Portfolios and Specifications
Table 88. Thermo Fisher PD-1 Antibody Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 89. Thermo Fisher Main Business
Table 90. Thermo Fisher Latest Developments
Table 91. InvivoGen Basic Information, PD-1 Antibody Drug Manufacturing Base, Sales Area and Its Competitors
Table 92. InvivoGen PD-1 Antibody Drug Product Portfolios and Specifications
Table 93. InvivoGen PD-1 Antibody Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 94. InvivoGen Main Business
Table 95. InvivoGen Latest Developments
Table 96. BioVision Inc. Basic Information, PD-1 Antibody Drug Manufacturing Base, Sales Area and Its Competitors
Table 97. BioVision Inc. PD-1 Antibody Drug Product Portfolios and Specifications
Table 98. BioVision Inc. PD-1 Antibody Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 99. BioVision Inc. Main Business
Table 100. BioVision Inc. Latest Developments
Table 101. Abcam Basic Information, PD-1 Antibody Drug Manufacturing Base, Sales Area and Its Competitors
Table 102. Abcam PD-1 Antibody Drug Product Portfolios and Specifications
Table 103. Abcam PD-1 Antibody Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 104. Abcam Main Business
Table 105. Abcam Latest Developments
Table 106. Bristol-Myers Squibb Basic Information, PD-1 Antibody Drug Manufacturing Base, Sales Area and Its Competitors
Table 107. Bristol-Myers Squibb PD-1 Antibody Drug Product Portfolios and Specifications
Table 108. Bristol-Myers Squibb PD-1 Antibody Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 109. Bristol-Myers Squibb Main Business
Table 110. Bristol-Myers Squibb Latest Developments
Table 111. Merck Basic Information, PD-1 Antibody Drug Manufacturing Base, Sales Area and Its Competitors
Table 112. Merck PD-1 Antibody Drug Product Portfolios and Specifications
Table 113. Merck PD-1 Antibody Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 114. Merck Main Business
Table 115. Merck Latest Developments
Table 116. Ono Pharmaceutical Co., Ltd Basic Information, PD-1 Antibody Drug Manufacturing Base, Sales Area and Its Competitors
Table 117. Ono Pharmaceutical Co., Ltd PD-1 Antibody Drug Product Portfolios and Specifications
Table 118. Ono Pharmaceutical Co., Ltd PD-1 Antibody Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 119. Ono Pharmaceutical Co., Ltd Main Business
Table 120. Ono Pharmaceutical Co., Ltd Latest Developments
Table 121. Eli Lilly Basic Information, PD-1 Antibody Drug Manufacturing Base, Sales Area and Its Competitors
Table 122. Eli Lilly PD-1 Antibody Drug Product Portfolios and Specifications
Table 123. Eli Lilly PD-1 Antibody Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 124. Eli Lilly Main Business
Table 125. Eli Lilly Latest Developments
Table 126. Chugai Pharmaceutical Co., Ltd Basic Information, PD-1 Antibody Drug Manufacturing Base, Sales Area and Its Competitors
Table 127. Chugai Pharmaceutical Co., Ltd PD-1 Antibody Drug Product Portfolios and Specifications
Table 128. Chugai Pharmaceutical Co., Ltd PD-1 Antibody Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 129. Chugai Pharmaceutical Co., Ltd Main Business
Table 130. Chugai Pharmaceutical Co., Ltd Latest Developments
Table 131. BeiGene Basic Information, PD-1 Antibody Drug Manufacturing Base, Sales Area and Its Competitors
Table 132. BeiGene PD-1 Antibody Drug Product Portfolios and Specifications
Table 133. BeiGene PD-1 Antibody Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 134. BeiGene Main Business
Table 135. BeiGene Latest Developments
Table 136. AbbVie Basic Information, PD-1 Antibody Drug Manufacturing Base, Sales Area and Its Competitors
Table 137. AbbVie PD-1 Antibody Drug Product Portfolios and Specifications
Table 138. AbbVie PD-1 Antibody Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 139. AbbVie Main Business
Table 140. AbbVie Latest Developments
Table 141. TG Therapeutics, Inc Basic Information, PD-1 Antibody Drug Manufacturing Base, Sales Area and Its Competitors
Table 142. TG Therapeutics, Inc PD-1 Antibody Drug Product Portfolios and Specifications
Table 143. TG Therapeutics, Inc PD-1 Antibody Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 144. TG Therapeutics, Inc Main Business
Table 145. TG Therapeutics, Inc Latest Developments
Table 146. Beijing Yiqiao Shenzhou Technology Co., Ltd. Basic Information, PD-1 Antibody Drug Manufacturing Base, Sales Area and Its Competitors
Table 147. Beijing Yiqiao Shenzhou Technology Co., Ltd. PD-1 Antibody Drug Product Portfolios and Specifications
Table 148. Beijing Yiqiao Shenzhou Technology Co., Ltd. PD-1 Antibody Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 149. Beijing Yiqiao Shenzhou Technology Co., Ltd. Main Business
Table 150. Beijing Yiqiao Shenzhou Technology Co., Ltd. Latest Developments
Table 151. 3SBio Basic Information, PD-1 Antibody Drug Manufacturing Base, Sales Area and Its Competitors
Table 152. 3SBio PD-1 Antibody Drug Product Portfolios and Specifications
Table 153. 3SBio PD-1 Antibody Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 154. 3SBio Main Business
Table 155. 3SBio Latest Developments
Table 1. PD-1 Antibody Drug Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. PD-1 Antibody Drug Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Pembrolizumab
Table 4. Major Players of Nivolumab
Table 5. Major Players of Sindilimab
Table 6. Major Players of Toripalimab
Table 7. Major Players of Other
Table 8. Global PD-1 Antibody Drug Sales by Type (2019-2024) & (K Units)
Table 9. Global PD-1 Antibody Drug Sales Market Share by Type (2019-2024)
Table 10. Global PD-1 Antibody Drug Revenue by Type (2019-2024) & ($ million)
Table 11. Global PD-1 Antibody Drug Revenue Market Share by Type (2019-2024)
Table 12. Global PD-1 Antibody Drug Sale Price by Type (2019-2024) & (US$/Unit)
Table 13. Global PD-1 Antibody Drug Sales by Application (2019-2024) & (K Units)
Table 14. Global PD-1 Antibody Drug Sales Market Share by Application (2019-2024)
Table 15. Global PD-1 Antibody Drug Revenue by Application (2019-2024)
Table 16. Global PD-1 Antibody Drug Revenue Market Share by Application (2019-2024)
Table 17. Global PD-1 Antibody Drug Sale Price by Application (2019-2024) & (US$/Unit)
Table 18. Global PD-1 Antibody Drug Sales by Company (2019-2024) & (K Units)
Table 19. Global PD-1 Antibody Drug Sales Market Share by Company (2019-2024)
Table 20. Global PD-1 Antibody Drug Revenue by Company (2019-2024) ($ Millions)
Table 21. Global PD-1 Antibody Drug Revenue Market Share by Company (2019-2024)
Table 22. Global PD-1 Antibody Drug Sale Price by Company (2019-2024) & (US$/Unit)
Table 23. Key Manufacturers PD-1 Antibody Drug Producing Area Distribution and Sales Area
Table 24. Players PD-1 Antibody Drug Products Offered
Table 25. PD-1 Antibody Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global PD-1 Antibody Drug Sales by Geographic Region (2019-2024) & (K Units)
Table 29. Global PD-1 Antibody Drug Sales Market Share Geographic Region (2019-2024)
Table 30. Global PD-1 Antibody Drug Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global PD-1 Antibody Drug Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global PD-1 Antibody Drug Sales by Country/Region (2019-2024) & (K Units)
Table 33. Global PD-1 Antibody Drug Sales Market Share by Country/Region (2019-2024)
Table 34. Global PD-1 Antibody Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global PD-1 Antibody Drug Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas PD-1 Antibody Drug Sales by Country (2019-2024) & (K Units)
Table 37. Americas PD-1 Antibody Drug Sales Market Share by Country (2019-2024)
Table 38. Americas PD-1 Antibody Drug Revenue by Country (2019-2024) & ($ Millions)
Table 39. Americas PD-1 Antibody Drug Revenue Market Share by Country (2019-2024)
Table 40. Americas PD-1 Antibody Drug Sales by Type (2019-2024) & (K Units)
Table 41. Americas PD-1 Antibody Drug Sales by Application (2019-2024) & (K Units)
Table 42. APAC PD-1 Antibody Drug Sales by Region (2019-2024) & (K Units)
Table 43. APAC PD-1 Antibody Drug Sales Market Share by Region (2019-2024)
Table 44. APAC PD-1 Antibody Drug Revenue by Region (2019-2024) & ($ Millions)
Table 45. APAC PD-1 Antibody Drug Revenue Market Share by Region (2019-2024)
Table 46. APAC PD-1 Antibody Drug Sales by Type (2019-2024) & (K Units)
Table 47. APAC PD-1 Antibody Drug Sales by Application (2019-2024) & (K Units)
Table 48. Europe PD-1 Antibody Drug Sales by Country (2019-2024) & (K Units)
Table 49. Europe PD-1 Antibody Drug Sales Market Share by Country (2019-2024)
Table 50. Europe PD-1 Antibody Drug Revenue by Country (2019-2024) & ($ Millions)
Table 51. Europe PD-1 Antibody Drug Revenue Market Share by Country (2019-2024)
Table 52. Europe PD-1 Antibody Drug Sales by Type (2019-2024) & (K Units)
Table 53. Europe PD-1 Antibody Drug Sales by Application (2019-2024) & (K Units)
Table 54. Middle East & Africa PD-1 Antibody Drug Sales by Country (2019-2024) & (K Units)
Table 55. Middle East & Africa PD-1 Antibody Drug Sales Market Share by Country (2019-2024)
Table 56. Middle East & Africa PD-1 Antibody Drug Revenue by Country (2019-2024) & ($ Millions)
Table 57. Middle East & Africa PD-1 Antibody Drug Revenue Market Share by Country (2019-2024)
Table 58. Middle East & Africa PD-1 Antibody Drug Sales by Type (2019-2024) & (K Units)
Table 59. Middle East & Africa PD-1 Antibody Drug Sales by Application (2019-2024) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of PD-1 Antibody Drug
Table 61. Key Market Challenges & Risks of PD-1 Antibody Drug
Table 62. Key Industry Trends of PD-1 Antibody Drug
Table 63. PD-1 Antibody Drug Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. PD-1 Antibody Drug Distributors List
Table 66. PD-1 Antibody Drug Customer List
Table 67. Global PD-1 Antibody Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 68. Global PD-1 Antibody Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 69. Americas PD-1 Antibody Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 70. Americas PD-1 Antibody Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. APAC PD-1 Antibody Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 72. APAC PD-1 Antibody Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Europe PD-1 Antibody Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Europe PD-1 Antibody Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Middle East & Africa PD-1 Antibody Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 76. Middle East & Africa PD-1 Antibody Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Global PD-1 Antibody Drug Sales Forecast by Type (2025-2030) & (K Units)
Table 78. Global PD-1 Antibody Drug Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 79. Global PD-1 Antibody Drug Sales Forecast by Application (2025-2030) & (K Units)
Table 80. Global PD-1 Antibody Drug Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 81. Novartis Basic Information, PD-1 Antibody Drug Manufacturing Base, Sales Area and Its Competitors
Table 82. Novartis PD-1 Antibody Drug Product Portfolios and Specifications
Table 83. Novartis PD-1 Antibody Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 84. Novartis Main Business
Table 85. Novartis Latest Developments
Table 86. Thermo Fisher Basic Information, PD-1 Antibody Drug Manufacturing Base, Sales Area and Its Competitors
Table 87. Thermo Fisher PD-1 Antibody Drug Product Portfolios and Specifications
Table 88. Thermo Fisher PD-1 Antibody Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 89. Thermo Fisher Main Business
Table 90. Thermo Fisher Latest Developments
Table 91. InvivoGen Basic Information, PD-1 Antibody Drug Manufacturing Base, Sales Area and Its Competitors
Table 92. InvivoGen PD-1 Antibody Drug Product Portfolios and Specifications
Table 93. InvivoGen PD-1 Antibody Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 94. InvivoGen Main Business
Table 95. InvivoGen Latest Developments
Table 96. BioVision Inc. Basic Information, PD-1 Antibody Drug Manufacturing Base, Sales Area and Its Competitors
Table 97. BioVision Inc. PD-1 Antibody Drug Product Portfolios and Specifications
Table 98. BioVision Inc. PD-1 Antibody Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 99. BioVision Inc. Main Business
Table 100. BioVision Inc. Latest Developments
Table 101. Abcam Basic Information, PD-1 Antibody Drug Manufacturing Base, Sales Area and Its Competitors
Table 102. Abcam PD-1 Antibody Drug Product Portfolios and Specifications
Table 103. Abcam PD-1 Antibody Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 104. Abcam Main Business
Table 105. Abcam Latest Developments
Table 106. Bristol-Myers Squibb Basic Information, PD-1 Antibody Drug Manufacturing Base, Sales Area and Its Competitors
Table 107. Bristol-Myers Squibb PD-1 Antibody Drug Product Portfolios and Specifications
Table 108. Bristol-Myers Squibb PD-1 Antibody Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 109. Bristol-Myers Squibb Main Business
Table 110. Bristol-Myers Squibb Latest Developments
Table 111. Merck Basic Information, PD-1 Antibody Drug Manufacturing Base, Sales Area and Its Competitors
Table 112. Merck PD-1 Antibody Drug Product Portfolios and Specifications
Table 113. Merck PD-1 Antibody Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 114. Merck Main Business
Table 115. Merck Latest Developments
Table 116. Ono Pharmaceutical Co., Ltd Basic Information, PD-1 Antibody Drug Manufacturing Base, Sales Area and Its Competitors
Table 117. Ono Pharmaceutical Co., Ltd PD-1 Antibody Drug Product Portfolios and Specifications
Table 118. Ono Pharmaceutical Co., Ltd PD-1 Antibody Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 119. Ono Pharmaceutical Co., Ltd Main Business
Table 120. Ono Pharmaceutical Co., Ltd Latest Developments
Table 121. Eli Lilly Basic Information, PD-1 Antibody Drug Manufacturing Base, Sales Area and Its Competitors
Table 122. Eli Lilly PD-1 Antibody Drug Product Portfolios and Specifications
Table 123. Eli Lilly PD-1 Antibody Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 124. Eli Lilly Main Business
Table 125. Eli Lilly Latest Developments
Table 126. Chugai Pharmaceutical Co., Ltd Basic Information, PD-1 Antibody Drug Manufacturing Base, Sales Area and Its Competitors
Table 127. Chugai Pharmaceutical Co., Ltd PD-1 Antibody Drug Product Portfolios and Specifications
Table 128. Chugai Pharmaceutical Co., Ltd PD-1 Antibody Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 129. Chugai Pharmaceutical Co., Ltd Main Business
Table 130. Chugai Pharmaceutical Co., Ltd Latest Developments
Table 131. BeiGene Basic Information, PD-1 Antibody Drug Manufacturing Base, Sales Area and Its Competitors
Table 132. BeiGene PD-1 Antibody Drug Product Portfolios and Specifications
Table 133. BeiGene PD-1 Antibody Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 134. BeiGene Main Business
Table 135. BeiGene Latest Developments
Table 136. AbbVie Basic Information, PD-1 Antibody Drug Manufacturing Base, Sales Area and Its Competitors
Table 137. AbbVie PD-1 Antibody Drug Product Portfolios and Specifications
Table 138. AbbVie PD-1 Antibody Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 139. AbbVie Main Business
Table 140. AbbVie Latest Developments
Table 141. TG Therapeutics, Inc Basic Information, PD-1 Antibody Drug Manufacturing Base, Sales Area and Its Competitors
Table 142. TG Therapeutics, Inc PD-1 Antibody Drug Product Portfolios and Specifications
Table 143. TG Therapeutics, Inc PD-1 Antibody Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 144. TG Therapeutics, Inc Main Business
Table 145. TG Therapeutics, Inc Latest Developments
Table 146. Beijing Yiqiao Shenzhou Technology Co., Ltd. Basic Information, PD-1 Antibody Drug Manufacturing Base, Sales Area and Its Competitors
Table 147. Beijing Yiqiao Shenzhou Technology Co., Ltd. PD-1 Antibody Drug Product Portfolios and Specifications
Table 148. Beijing Yiqiao Shenzhou Technology Co., Ltd. PD-1 Antibody Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 149. Beijing Yiqiao Shenzhou Technology Co., Ltd. Main Business
Table 150. Beijing Yiqiao Shenzhou Technology Co., Ltd. Latest Developments
Table 151. 3SBio Basic Information, PD-1 Antibody Drug Manufacturing Base, Sales Area and Its Competitors
Table 152. 3SBio PD-1 Antibody Drug Product Portfolios and Specifications
Table 153. 3SBio PD-1 Antibody Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 154. 3SBio Main Business
Table 155. 3SBio Latest Developments
LIST OF FIGURES
Figure 1. Picture of PD-1 Antibody Drug
Figure 2. PD-1 Antibody Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global PD-1 Antibody Drug Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global PD-1 Antibody Drug Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. PD-1 Antibody Drug Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Pembrolizumab
Figure 10. Product Picture of Nivolumab
Figure 11. Product Picture of Sindilimab
Figure 12. Product Picture of Toripalimab
Figure 13. Product Picture of Other
Figure 14. Global PD-1 Antibody Drug Sales Market Share by Type in 2023
Figure 15. Global PD-1 Antibody Drug Revenue Market Share by Type (2019-2024)
Figure 16. PD-1 Antibody Drug Consumed in Hospital
Figure 17. Global PD-1 Antibody Drug Market: Hospital (2019-2024) & (K Units)
Figure 18. PD-1 Antibody Drug Consumed in Clinic
Figure 19. Global PD-1 Antibody Drug Market: Clinic (2019-2024) & (K Units)
Figure 20. PD-1 Antibody Drug Consumed in Other
Figure 21. Global PD-1 Antibody Drug Market: Other (2019-2024) & (K Units)
Figure 22. Global PD-1 Antibody Drug Sales Market Share by Application (2023)
Figure 23. Global PD-1 Antibody Drug Revenue Market Share by Application in 2023
Figure 24. PD-1 Antibody Drug Sales Market by Company in 2023 (K Units)
Figure 25. Global PD-1 Antibody Drug Sales Market Share by Company in 2023
Figure 26. PD-1 Antibody Drug Revenue Market by Company in 2023 ($ Million)
Figure 27. Global PD-1 Antibody Drug Revenue Market Share by Company in 2023
Figure 28. Global PD-1 Antibody Drug Sales Market Share by Geographic Region (2019-2024)
Figure 29. Global PD-1 Antibody Drug Revenue Market Share by Geographic Region in 2023
Figure 30. Americas PD-1 Antibody Drug Sales 2019-2024 (K Units)
Figure 31. Americas PD-1 Antibody Drug Revenue 2019-2024 ($ Millions)
Figure 32. APAC PD-1 Antibody Drug Sales 2019-2024 (K Units)
Figure 33. APAC PD-1 Antibody Drug Revenue 2019-2024 ($ Millions)
Figure 34. Europe PD-1 Antibody Drug Sales 2019-2024 (K Units)
Figure 35. Europe PD-1 Antibody Drug Revenue 2019-2024 ($ Millions)
Figure 36. Middle East & Africa PD-1 Antibody Drug Sales 2019-2024 (K Units)
Figure 37. Middle East & Africa PD-1 Antibody Drug Revenue 2019-2024 ($ Millions)
Figure 38. Americas PD-1 Antibody Drug Sales Market Share by Country in 2023
Figure 39. Americas PD-1 Antibody Drug Revenue Market Share by Country in 2023
Figure 40. Americas PD-1 Antibody Drug Sales Market Share by Type (2019-2024)
Figure 41. Americas PD-1 Antibody Drug Sales Market Share by Application (2019-2024)
Figure 42. United States PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 43. Canada PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 44. Mexico PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 45. Brazil PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 46. APAC PD-1 Antibody Drug Sales Market Share by Region in 2023
Figure 47. APAC PD-1 Antibody Drug Revenue Market Share by Regions in 2023
Figure 48. APAC PD-1 Antibody Drug Sales Market Share by Type (2019-2024)
Figure 49. APAC PD-1 Antibody Drug Sales Market Share by Application (2019-2024)
Figure 50. China PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 51. Japan PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 52. South Korea PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 53. Southeast Asia PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 54. India PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 55. Australia PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 56. China Taiwan PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 57. Europe PD-1 Antibody Drug Sales Market Share by Country in 2023
Figure 58. Europe PD-1 Antibody Drug Revenue Market Share by Country in 2023
Figure 59. Europe PD-1 Antibody Drug Sales Market Share by Type (2019-2024)
Figure 60. Europe PD-1 Antibody Drug Sales Market Share by Application (2019-2024)
Figure 61. Germany PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 62. France PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 63. UK PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 64. Italy PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 65. Russia PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 66. Middle East & Africa PD-1 Antibody Drug Sales Market Share by Country in 2023
Figure 67. Middle East & Africa PD-1 Antibody Drug Revenue Market Share by Country in 2023
Figure 68. Middle East & Africa PD-1 Antibody Drug Sales Market Share by Type (2019-2024)
Figure 69. Middle East & Africa PD-1 Antibody Drug Sales Market Share by Application (2019-2024)
Figure 70. Egypt PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 71. South Africa PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 72. Israel PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 73. Turkey PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 74. GCC Country PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of PD-1 Antibody Drug in 2023
Figure 76. Manufacturing Process Analysis of PD-1 Antibody Drug
Figure 77. Industry Chain Structure of PD-1 Antibody Drug
Figure 78. Channels of Distribution
Figure 79. Global PD-1 Antibody Drug Sales Market Forecast by Region (2025-2030)
Figure 80. Global PD-1 Antibody Drug Revenue Market Share Forecast by Region (2025-2030)
Figure 81. Global PD-1 Antibody Drug Sales Market Share Forecast by Type (2025-2030)
Figure 82. Global PD-1 Antibody Drug Revenue Market Share Forecast by Type (2025-2030)
Figure 83. Global PD-1 Antibody Drug Sales Market Share Forecast by Application (2025-2030)
Figure 84. Global PD-1 Antibody Drug Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of PD-1 Antibody Drug
Figure 2. PD-1 Antibody Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global PD-1 Antibody Drug Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global PD-1 Antibody Drug Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. PD-1 Antibody Drug Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Pembrolizumab
Figure 10. Product Picture of Nivolumab
Figure 11. Product Picture of Sindilimab
Figure 12. Product Picture of Toripalimab
Figure 13. Product Picture of Other
Figure 14. Global PD-1 Antibody Drug Sales Market Share by Type in 2023
Figure 15. Global PD-1 Antibody Drug Revenue Market Share by Type (2019-2024)
Figure 16. PD-1 Antibody Drug Consumed in Hospital
Figure 17. Global PD-1 Antibody Drug Market: Hospital (2019-2024) & (K Units)
Figure 18. PD-1 Antibody Drug Consumed in Clinic
Figure 19. Global PD-1 Antibody Drug Market: Clinic (2019-2024) & (K Units)
Figure 20. PD-1 Antibody Drug Consumed in Other
Figure 21. Global PD-1 Antibody Drug Market: Other (2019-2024) & (K Units)
Figure 22. Global PD-1 Antibody Drug Sales Market Share by Application (2023)
Figure 23. Global PD-1 Antibody Drug Revenue Market Share by Application in 2023
Figure 24. PD-1 Antibody Drug Sales Market by Company in 2023 (K Units)
Figure 25. Global PD-1 Antibody Drug Sales Market Share by Company in 2023
Figure 26. PD-1 Antibody Drug Revenue Market by Company in 2023 ($ Million)
Figure 27. Global PD-1 Antibody Drug Revenue Market Share by Company in 2023
Figure 28. Global PD-1 Antibody Drug Sales Market Share by Geographic Region (2019-2024)
Figure 29. Global PD-1 Antibody Drug Revenue Market Share by Geographic Region in 2023
Figure 30. Americas PD-1 Antibody Drug Sales 2019-2024 (K Units)
Figure 31. Americas PD-1 Antibody Drug Revenue 2019-2024 ($ Millions)
Figure 32. APAC PD-1 Antibody Drug Sales 2019-2024 (K Units)
Figure 33. APAC PD-1 Antibody Drug Revenue 2019-2024 ($ Millions)
Figure 34. Europe PD-1 Antibody Drug Sales 2019-2024 (K Units)
Figure 35. Europe PD-1 Antibody Drug Revenue 2019-2024 ($ Millions)
Figure 36. Middle East & Africa PD-1 Antibody Drug Sales 2019-2024 (K Units)
Figure 37. Middle East & Africa PD-1 Antibody Drug Revenue 2019-2024 ($ Millions)
Figure 38. Americas PD-1 Antibody Drug Sales Market Share by Country in 2023
Figure 39. Americas PD-1 Antibody Drug Revenue Market Share by Country in 2023
Figure 40. Americas PD-1 Antibody Drug Sales Market Share by Type (2019-2024)
Figure 41. Americas PD-1 Antibody Drug Sales Market Share by Application (2019-2024)
Figure 42. United States PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 43. Canada PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 44. Mexico PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 45. Brazil PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 46. APAC PD-1 Antibody Drug Sales Market Share by Region in 2023
Figure 47. APAC PD-1 Antibody Drug Revenue Market Share by Regions in 2023
Figure 48. APAC PD-1 Antibody Drug Sales Market Share by Type (2019-2024)
Figure 49. APAC PD-1 Antibody Drug Sales Market Share by Application (2019-2024)
Figure 50. China PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 51. Japan PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 52. South Korea PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 53. Southeast Asia PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 54. India PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 55. Australia PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 56. China Taiwan PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 57. Europe PD-1 Antibody Drug Sales Market Share by Country in 2023
Figure 58. Europe PD-1 Antibody Drug Revenue Market Share by Country in 2023
Figure 59. Europe PD-1 Antibody Drug Sales Market Share by Type (2019-2024)
Figure 60. Europe PD-1 Antibody Drug Sales Market Share by Application (2019-2024)
Figure 61. Germany PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 62. France PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 63. UK PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 64. Italy PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 65. Russia PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 66. Middle East & Africa PD-1 Antibody Drug Sales Market Share by Country in 2023
Figure 67. Middle East & Africa PD-1 Antibody Drug Revenue Market Share by Country in 2023
Figure 68. Middle East & Africa PD-1 Antibody Drug Sales Market Share by Type (2019-2024)
Figure 69. Middle East & Africa PD-1 Antibody Drug Sales Market Share by Application (2019-2024)
Figure 70. Egypt PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 71. South Africa PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 72. Israel PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 73. Turkey PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 74. GCC Country PD-1 Antibody Drug Revenue Growth 2019-2024 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of PD-1 Antibody Drug in 2023
Figure 76. Manufacturing Process Analysis of PD-1 Antibody Drug
Figure 77. Industry Chain Structure of PD-1 Antibody Drug
Figure 78. Channels of Distribution
Figure 79. Global PD-1 Antibody Drug Sales Market Forecast by Region (2025-2030)
Figure 80. Global PD-1 Antibody Drug Revenue Market Share Forecast by Region (2025-2030)
Figure 81. Global PD-1 Antibody Drug Sales Market Share Forecast by Type (2025-2030)
Figure 82. Global PD-1 Antibody Drug Revenue Market Share Forecast by Type (2025-2030)
Figure 83. Global PD-1 Antibody Drug Sales Market Share Forecast by Application (2025-2030)
Figure 84. Global PD-1 Antibody Drug Revenue Market Share Forecast by Application (2025-2030)
